Bela Shah

459 total citations
52 papers, 249 citations indexed

About

Bela Shah is a scholar working on Pathology and Forensic Medicine, Dermatology and Rheumatology. According to data from OpenAlex, Bela Shah has authored 52 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 14 papers in Dermatology and 13 papers in Rheumatology. Recurrent topics in Bela Shah's work include Autoimmune Bullous Skin Diseases (15 papers), Urticaria and Related Conditions (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers). Bela Shah is often cited by papers focused on Autoimmune Bullous Skin Diseases (15 papers), Urticaria and Related Conditions (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers). Bela Shah collaborates with scholars based in India, United States and Canada. Bela Shah's co-authors include Abhishek De, Kiran Godse, Vijay Zawar, Murlidhar Rajagopalan, Mira Desai, Hanmant Barkate, A Nandakumar, Ramnath Takiar, Priti Gupta and Usha K. Luthra and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Transplantation and Dermatologic Surgery.

In The Last Decade

Bela Shah

41 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bela Shah India 9 96 76 73 48 33 52 249
Luisa Lunardon Italy 8 154 1.6× 143 1.9× 52 0.7× 96 2.0× 20 0.6× 15 300
F. Tétart France 9 126 1.3× 66 0.9× 106 1.5× 22 0.5× 31 0.9× 48 285
Amer N. Kalaaji United States 12 90 0.9× 143 1.9× 98 1.3× 66 1.4× 104 3.2× 32 336
J.M. Bonnetblanc France 10 70 0.7× 69 0.9× 47 0.6× 44 0.9× 63 1.9× 20 247
P. Duriez France 9 81 0.8× 57 0.8× 52 0.7× 33 0.7× 75 2.3× 18 220
PS Friedmann United Kingdom 10 92 1.0× 170 2.2× 96 1.3× 108 2.3× 34 1.0× 19 419
Maria Manuel Brites Portugal 9 130 1.4× 130 1.7× 165 2.3× 57 1.2× 122 3.7× 25 373
Lele Sun China 9 46 0.5× 52 0.7× 35 0.5× 11 0.2× 82 2.5× 40 243
Esen Özkaya‐Bayazit Türkiye 8 69 0.7× 71 0.9× 166 2.3× 17 0.4× 39 1.2× 12 336
Hao Trong Nguyen Vietnam 10 33 0.3× 32 0.4× 91 1.2× 19 0.4× 24 0.7× 37 251

Countries citing papers authored by Bela Shah

Since Specialization
Citations

This map shows the geographic impact of Bela Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bela Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bela Shah more than expected).

Fields of papers citing papers by Bela Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bela Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bela Shah. The network helps show where Bela Shah may publish in the future.

Co-authorship network of co-authors of Bela Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Bela Shah. A scholar is included among the top collaborators of Bela Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bela Shah. Bela Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shah, Bela, et al.. (2025). Recurrence of Oxalate Nephropathy After Roux en Y Gastric Bypass in a Live Donor Kidney Transplant. American Journal of Transplantation. 25(8). S863–S863.
3.
Bhat, RameshM, Sudip Das, Kiran Godse, et al.. (2024). Indian expert Delphi consensus on the diagnosis and management of flares of generalised pustular psoriasis. Indian Journal of Dermatology Venereology and Leprology. 91(3). 338–345.
4.
Thomas, Jayakar, Anil Ganjoo, Bela Shah, et al.. (2024). Delphi Consensus Statement on the Role of Probiotics in the Treatment of Atopic Dermatitis. Cureus. 16(7). e64583–e64583. 2 indexed citations
5.
Shah, Bela, et al.. (2024). Role of dermoscopy in hyperpigmented skin disorders: A tertiary care centre experience. IP Indian Journal of Clinical and Experimental Dermatology. 9(4). 184–193.
6.
Shah, Bela, et al.. (2023). A single‐centre prospective study comparing efficacy and safety of apremilast with cyclosporine in moderate to severe atopic dermatitis. Australasian Journal of Dermatology. 64(4). e333–e339. 2 indexed citations
7.
Patel, Lav P., et al.. (2023). Effectiveness of Corticosteroids Alone versus Corticosteroids and Cyclosporine in the Management of Patients with Severe Cutaneous Drug Reaction. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 1 indexed citations
8.
Shah, Bela, et al.. (2023). A Clinical-Mycological Study of Dermatophytosis in Western India with Focus on Antifungal Drug Resistance as a Factor in Recalcitrance. Indian Journal of Dermatology. 68(2). 234–234. 4 indexed citations
9.
Shah, Bela, et al.. (2022). A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria. SHILAP Revista de lepidopterología. 10 indexed citations
10.
Shah, Bela, et al.. (2022). Long‐term efficacy and safety analysis of single cycle of biosimilar rituximab in pemphigus: A retrospective study of 76 patients from India. Dermatologic Therapy. 35(9). e15704–e15704. 1 indexed citations
12.
Godse, Kiran, Anant Patil, Abhishek De, et al.. (2022). Diagnosis and Management of Urticaria in Indian Settings. Indian Journal of Dermatology. 67(6). 732–743. 9 indexed citations
13.
Shah, Bela, et al.. (2020). Real world Indian experience of switchover to Bilastine in CSU patient refractory to other antihistamines. IP Indian Journal of Clinical and Experimental Dermatology. 6(4). 328–332. 2 indexed citations
14.
Godse, Kiran, et al.. (2019). Bilastine for the treatment of chronic spontaneous urticaria: Consensus statement for Indian patients. IP Indian Journal of Clinical and Experimental Dermatology. 5(3). 180–185. 5 indexed citations
15.
Shah, Bela, et al.. (2019). Cutaneous adverse drug reactions to targeted chemotherapeutic drugs: A clinico-epidemiological study. Indian Journal of Dermatology. 64(6). 471–471. 6 indexed citations
16.
Shah, Bela, et al.. (2016). A Study on Clinical Presentation of Dengue Fever in Children. International Journal of Science and Research (IJSR). 5(4). 2272–2275. 6 indexed citations
17.
Godse, Kiran, et al.. (2016). Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients. Indian Dermatology Online Journal. 7(1). 6–11. 8 indexed citations
18.
Shah, Bela, et al.. (2015). Naegeli-Franceschetti-Jadassohn syndrome: A rare case. Indian Dermatology Online Journal. 6(6). 403–403. 5 indexed citations
20.
Shah, Bela, et al.. (2009). Clinical Evaluation of an Indian Polyherbal Topical Formulation in the Management of Eczema. The Journal of Alternative and Complementary Medicine. 15(6). 669–672. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026